Clover Health's Strategic Approach to Medicare Advantage Growth
With a unique business model, Clover Health demonstrates confidence in achieving above-market membership growth and strong Adjusted EBITDA profitability through 2027, regardless of Star ratings.
Clover Health Investments, Corp. (Nasdaq: CLOV) is dedicated to transforming the accessibility of high-quality healthcare for Medicare beneficiaries. In light of the Centers for Medicare & Medicaid Services' (CMS) announcement regarding the 2026 Star ratings, Clover Health made significant comments on its positioning in the Medicare Advantage (MA) landscape. Its PPO MA plans received a commendable score of 3.5 Stars, while the HMO MA plan garnered a notable 4.0 Stars, affecting the payment year 2027.
Andrew Toy, the Chief Executive Officer of Clover Health, expressed that their technology-driven care approach allows them to navigate the complexities of Star ratings effectively. "Our year-on-year improvements driven by AI in our Clover Assistant platform afford us the ability to sustain our business model, independent of Star ratings, ensuring wide-ranging network benefits for our members," Toy stated.
The company achieved impressive results through the first half of 2025, mirroring projections for 2027. Clover's revenues soared by 34%, and membership experienced a 32% growth, maintaining a strong Adjusted EBITDA profitability, showcasing a robust performance in a comparable Star rating year.
Commitment to Clinical Excellence
Clover Health demonstrated outstanding performance in clinical quality measures. It scored an impressive 4.72 for its PPO plans on HEDIS clinical quality measures, largely attributed to the capabilities of Clover Assistant, which facilitates superior patient care.
From a health policy perspective, Clover Health advocates that the Star rating system does not adequately reflect the superior health outcomes it achieves for its members. The company argues that the methodology prioritizes non-outcomes measures, such as member satisfaction and administrative metrics, rather than focusing on tangible clinical results and health improvements.
Industry Insights and Future Directions
As the healthcare industry evolves, Clover Health anticipates a significant reevaluation by Congress and CMS regarding how quality is measured within the Star Ratings program. The ability to showcase tangible clinical outcomes, rather than being reliant on quality bonuses, will mark which plans succeed moving forward. Clover positions itself advantageously for this transition, remaining dedicated to enhancing health outcomes through its innovative technology and methodologies.
The company is optimistic regarding sustained above-market Medicare Advantage growth and profitability expansions in the upcoming years, driven by several key factors:
- Continuous development of AI-powered features within the Clover Assistant platform.
- Growing adoption of Clover Assistant technology by healthcare professionals, leading to improved care quality and reduced costs.
- Prioritizing member retention, which boosts strong cohort performance and enhances overall profitability.
- Optimizing operating leverage through effective management of fixed and variable costs associated with SG&A.
Understanding Non-GAAP Financial Measures
Clover Health employs non-GAAP measures, including Adjusted EBITDA, to provide clearer insights into its financial performance. These metrics are not aligned with GAAP standards; however, they offer valuable context for evaluating the company's operations and financial health over time. Management uses these metrics for internal assessments, as they highlight core operational performance while aiding in strategic planning.
Adjusted EBITDA, as defined by Clover Health, accounts for net income from operations before factoring in depreciation, interest expenses, non-recurring costs, and other adjustments. Such measures paint a clearer picture of financial performance and are essential for understanding the company's profitability trends.
About Clover Health
Clover Health (Nasdaq: CLOV) is dedicated to enhancing healthcare access for those on Medicare, particularly for seniors who traditionally face challenges in securing affordable, high-quality care. The company's innovative software platform, Clover Assistant, aggregates data to support clinical decisions and improve health outcomes through proactive management of chronic conditions.
Clover provides PPO and HMO Medicare Advantage plans, emphasizing high-choice options while extending technological benefits to a broader audience through its subsidiary, Counterpart Health, aimed at improving patient outcomes and reducing costs nationally.
Frequently Asked Questions
What are Clover Health's Medicare Advantage Star ratings for 2026?
Clover's PPO MA plans received 3.5 Stars, while its HMO MA plan was rated 4.0 Stars.
How did Clover Health perform financially in 2025?
Clover Health experienced a 34% increase in revenue and a 32% growth in membership in the first half of 2025.
What is Clover Assistant?
Clover Assistant is an innovative technology platform designed to enhance patient care and clinical decision-making through data aggregation.
How does Clover Health support its members?
Clover Health focuses on providing extensive network benefits and quality healthcare to its Medicare members while utilizing advanced technology to improve health outcomes.
What differentiates Clover Health from other plans?
Clover Health's commitment to technology-driven care and its focus on clinical outcomes set it apart from traditional Medicare Advantage plans that may rely more heavily on ratings and member surveys.
